Does EGFR targeted therapy change the natural history of EGFR mutant status?

J BUON. 2017 Mar-Apr;22(2):560-561.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Male
  • Middle Aged
  • Molecular Targeted Therapy
  • Mutation / genetics
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors